BINDING MOLECULES BINDING PD-L1 AND LAG-3

The present disclosure relates to antibody molecules which bind to programmed death-ligand 1 (PD-L1) and lymphocyte-activation gene 3 (LAG-3). The antibody molecules preferably comprise a CDR-based antigen binding site for PD-L1, and a LAG-3 antigen binding site which may be located in two or more s...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	EVERETT, Katy Louise, TUNA, Mihriban, KRAMAN, Matthew, KMIECIK, Katarzyna, SANDY, Nikole, WOLLERTON VAN HORCK, Francisca, HEBEIS, Barbara, CAMPBELL, Jamie, FAROUDI, Mustapha, GASPAR, Miguel, FOSH, Natalie
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!